Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Accord Healthcare Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (605)
Cancellation by sponsor (114)
Prescription medicine registration (44)
Australian public assessment report (AusPar) (3)

Date

2026 (37)
2025 (69)
2024 (32)
2023 (68)
2022 (85)
2021 (52)
2020 (48)
2019 (93)
2018 (64)
2017 (40)
2016 (70)
2015 (36)
2014 (33)
2013 (7)
2012 (16)
2011 (16)

Search

Sponsor content

766 result(s) found, displaying 551 to 560

MIDAZOLAM AN Midazolam (as hydrochloride) 15 mg/3 mL solution for injection ampoules Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
MIDAZOLAM AN Midazolam (as hydrochloride) 50 mg/10 mL solution for injection ampoules Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
DEXMEDETOMIDINE INTAS, DEXMEDETOMIDINE ACCORD (Accord Healthcare Pty Ltd)

11 June 2019

Prescription medicine registration

Active ingredients: dexmedetomidine.
GLYCOPYRROLATE ACCORD glycopyrronium bromide 0.6 mg/3 mL injection ampoules (237403)

6 June 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for GLYCOPYRROLATE ACCORD glycopyrronium bromide 0.6 mg/3 mL injection ampoules.
GLYCOPYRROLATE ACCORD glycopyrronium bromide 0.2 mg/1 mL injection ampoules (237760)

6 June 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for GLYCOPYRROLATE ACCORD glycopyrronium bromide 0.2 mg/1 mL injection ampoules.
EXACCORD TABLETS 25 MG exemestane 25mg tablets blister pack Cancelled under Section 30(1) (c) of the Act

22 May 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
TERIFLUNOMIDE INTAS, TERIFLAGIO, TERINTAS (Accord Healthcare Pty Ltd)

20 May 2019

Prescription medicine registration

Active ingredients: teriflunomide.
SOLIFENACIN AMEDA, VESICAN, SOLIFENACIN GENERICHEALTH, SEFICARE, SOLIFENACIN INTAS (Accord Healthcare Pty Ltd)

20 May 2019

Prescription medicine registration

Active ingredients: solifenacin succinate.
LYRACCORD Pregabalin 150 mg capsules blister pack (235834)

23 March 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LYRACCORD Pregabalin 150 mg capsules blister pack.
LYRACCORD Pregabalin 150 mg capsules bottle pack (235851)

23 March 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LYRACCORD Pregabalin 150 mg capsules bottle pack.

Pages

First page
Previous page
…
Page 52
Page 53
Page 54
Page 55
Current page 56
Page 57
Page 58
Page 59
Page 60
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.